NCT06546631View on ClinicalTrials.gov

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

RecruitingOBSERVATIONAL

Enrollment

55

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

February 28, 2027

Conditions

Glioma

Trial Locations (1)

Unknown

RECRUITING

Cork University Hospital, Cork

All Listed Sponsors

collaborator

University Hospital Waterford

OTHER

lead

University College Cork

OTHER